# GE HealthCare Technologies Inc.

Summary updated: 2026-10-02T08:51:44.853863Z
Canonical: https://finbar.com/research/companies/ge-healthcare-technologies

## Overview

GE HealthCare Technologies Inc. is a global medical-technology and healthcare-solutions company. It develops and provides medical equipment, pharmaceutical diagnostics, and digital, software, cloud, and AI-enabled solutions used in diagnosing and treating disease. Its stated purpose is “to create a world where healthcare has no limits.” [1](https://app.finbar.com/go?id=P22478598)

The company’s four reportable segments are Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics, spanning technologies such as CT, MR, ultrasound, patient monitoring, anesthesia, and imaging agents. It serves customers in more than 160 countries and had approximately 54,000 employees in 2025. [2](https://app.finbar.com/go?id=P102185265)[3](https://app.finbar.com/go?id=P79435366)[4](https://app.finbar.com/go?id=P25583711) Revenue for the year ended December 31, 2025 was $20.625 billion. [5](https://app.finbar.com/go?id=T7780819)
[1](https://app.finbar.com/go?id=P22478598)[2](https://app.finbar.com/go?id=P102185265)[3](https://app.finbar.com/go?id=P79435366)[4](https://app.finbar.com/go?id=P25583711)[5](https://app.finbar.com/go?id=T7780819)

## Products & services

GE HealthCare’s imaging products include molecular imaging systems—cyclotrons and chemistry-synthesis systems, PET, PET/CT, SPECT, PET/MR and nuclear medicine products—as well as CT scanners for multipurpose and specialty imaging, MR systems across different bore sizes and field strengths, and fixed, mobile and fluoroscopy X-ray systems. Its Women’s Health portfolio includes breast-imaging and biopsy-positioning systems and bone-density scanners. Imaging offerings also include AI-enabled software and applications, lifecycle upgrades, training, and data-integration and enterprise-connectivity solutions. [6](https://app.finbar.com/go?id=P20467286)[7](https://app.finbar.com/go?id=P85204909)[8](https://app.finbar.com/go?id=P6558573)[9](https://app.finbar.com/go?id=P38308709)[10](https://app.finbar.com/go?id=P78624346)[11](https://app.finbar.com/go?id=P61384239)[12](https://app.finbar.com/go?id=P113702022)

Ultrasound products cover point-of-care and handheld use, comprehensive care, and women’s health applications including obstetrics, gynecology and assisted reproductive medicine. Described capabilities include measurement and quantification, workflow automation, cross-modality networking, real-time and AI-guided scanning, and cloud technology. Procedural guidance products include cardiovascular and interventional solutions and surgical innovations. [13](https://app.finbar.com/go?id=P91589918)[14](https://app.finbar.com/go?id=P29609717)[15](https://app.finbar.com/go?id=P99511486) Patient Care Solutions include multi-parameter and central-station monitors, wearable, mobile, transport and spot-check monitors, telemetry and diagnostic cardiology systems, as well as maternal-infant and anesthesia products. Maternal-infant offerings include neonatal incubators, infant warmers, resuscitation devices, phototherapy, maternal/fetal monitors and surveillance software; related digital applications, services and consumables are also offered. [16](https://app.finbar.com/go?id=P53106049)[17](https://app.finbar.com/go?id=P81258573)[18](https://app.finbar.com/go?id=P121080232)

Pharmaceutical Diagnostics products include contrast media for CT, angiography, X-ray, MR and ultrasound, and radiopharmaceutical agents used in SPECT and PET imaging to visualize cellular function and support disease assessment; these products are compatible with GE HealthCare and other vendors’ imaging equipment. [19](https://app.finbar.com/go?id=P37389307)[20](https://app.finbar.com/go?id=P28638867)[21](https://app.finbar.com/go?id=P22466455) Services include product installation and servicing, field engineering, repair centers and customer-service support. [22](https://app.finbar.com/go?id=P58194947)[23](https://app.finbar.com/go?id=P46885042) The available product disclosures do not specify sales or performance percentages for individual product categories. [24](https://app.finbar.com/go?id=T16498076)
[6](https://app.finbar.com/go?id=P20467286)[7](https://app.finbar.com/go?id=P85204909)[8](https://app.finbar.com/go?id=P6558573)[9](https://app.finbar.com/go?id=P38308709)[10](https://app.finbar.com/go?id=P78624346)[11](https://app.finbar.com/go?id=P61384239)[12](https://app.finbar.com/go?id=P113702022)[13](https://app.finbar.com/go?id=P91589918)[14](https://app.finbar.com/go?id=P29609717)[15](https://app.finbar.com/go?id=P99511486)[16](https://app.finbar.com/go?id=P53106049)[17](https://app.finbar.com/go?id=P81258573)[18](https://app.finbar.com/go?id=P121080232)[19](https://app.finbar.com/go?id=P37389307)[20](https://app.finbar.com/go?id=P28638867)[21](https://app.finbar.com/go?id=P22466455)[22](https://app.finbar.com/go?id=P58194947)[23](https://app.finbar.com/go?id=P46885042)[24](https://app.finbar.com/go?id=T16498076)

## Geographic presence

GE HealthCare reports revenue across four regions. In FY2025, revenue was $9.531 billion in the United States and Canada (46.2% of total), $5.425 billion in Europe, the Middle East and Africa (26.3%), $2.251 billion in the China region (10.9%), and $3.418 billion in the Rest of World (16.6%). Percentages are calculated from reported revenue of $20.625 billion; the company does not provide a country-level breakdown. [25](https://app.finbar.com/go?id=T2474700) For the six months ended June 30, 2026, the corresponding regional shares were 46.4%, 25.8%, 11.0% and 16.8%, respectively. [26](https://app.finbar.com/go?id=T16498074)

The company describes its operations as spanning manufacturing in 20 countries and research and development in 18 countries, serving customers in more than 160 countries. It reports more than 54,000 employees, but does not provide their geographic distribution. [27](https://careers.gehealthcare.com/global/en/about-gehc) Examples of named locations include Beijing, Wuxi, Tianjin, Shanghai, Chengdu and Shenzhen in China; Bengaluru in India; Tokyo and Hino in Japan; and Cork/Carrigtohill in Ireland. These are examples, not a complete facilities list. [28](https://careers.gehealthcare.com/global/en/locations) [29](https://www.gehealthcare.com/en/about/ge-healthcare-offices) [30](https://investor.gehealthcare.com/news-releases/news-release-details/ge-healthcare-invests-138-million-cork-ireland-manufacturing)
[25](https://app.finbar.com/go?id=T2474700)[26](https://app.finbar.com/go?id=T16498074)[27](https://careers.gehealthcare.com/global/en/about-gehc)[28](https://careers.gehealthcare.com/global/en/locations)[29](https://www.gehealthcare.com/en/about/ge-healthcare-offices)[30](https://investor.gehealthcare.com/news-releases/news-release-details/ge-healthcare-invests-138-million-cork-ireland-manufacturing)[27](https://careers.gehealthcare.com/global/en/about-gehc)[28](https://careers.gehealthcare.com/global/en/locations)[29](https://www.gehealthcare.com/en/about/ge-healthcare-offices)[30](https://investor.gehealthcare.com/news-releases/news-release-details/ge-healthcare-invests-138-million-cork-ireland-manufacturing)

## Business segments

GE HealthCare reported four operating segments in its 2025 full-year reporting. Imaging generated $9.245 billion, approximately 44.8% of total revenue, and covers Molecular Imaging, CT, MR, Women’s Health and X-ray, including related services. [31](https://app.finbar.com/go?id=T12070095)[32](https://app.finbar.com/go?id=P19851741)[33](https://app.finbar.com/go?id=P53323836)[6](https://app.finbar.com/go?id=P20467286)[7](https://app.finbar.com/go?id=P85204909)[8](https://app.finbar.com/go?id=P6558573)[9](https://app.finbar.com/go?id=P38308709)[10](https://app.finbar.com/go?id=P78624346) Advanced Visualization Solutions (AVS) generated $5.354 billion, about 26.0%, spanning Specialized Ultrasound and Procedural Guidance, including cardiovascular and interventional solutions and surgical innovations. [31](https://app.finbar.com/go?id=T12070095)[13](https://app.finbar.com/go?id=P91589918)[14](https://app.finbar.com/go?id=P29609717)[15](https://app.finbar.com/go?id=P99511486)[34](https://app.finbar.com/go?id=P53536457)[35](https://app.finbar.com/go?id=P94434843)[36](https://app.finbar.com/go?id=P95678361)

Patient Care Solutions (PCS) generated $3.086 billion, about 15.0%, with Monitoring Solutions—including patient monitoring and diagnostic cardiology—and Life Support Solutions, including maternal-infant care and anesthesia. [31](https://app.finbar.com/go?id=T12070095)[16](https://app.finbar.com/go?id=P53106049)[17](https://app.finbar.com/go?id=P81258573)[37](https://app.finbar.com/go?id=P61448767)[18](https://app.finbar.com/go?id=P121080232)[38](https://app.finbar.com/go?id=P67720151)[39](https://app.finbar.com/go?id=P16267018)[40](https://app.finbar.com/go?id=P9360703) Pharmaceutical Diagnostics (PDx) generated $2.900 billion, about 14.1%, supplying contrast media, radiopharmaceutical imaging agents and contrast injection devices for imaging applications. [31](https://app.finbar.com/go?id=T12070095)[19](https://app.finbar.com/go?id=P37389307)[41](https://app.finbar.com/go?id=P116356463)[20](https://app.finbar.com/go?id=P28638867)[21](https://app.finbar.com/go?id=P22466455) Percentages are calculated against 2025 total revenue of $20.625 billion, including $40 million of Other revenue (about 0.2%), which was attributed to HealthCare Financial Services and was not an operating segment. [31](https://app.finbar.com/go?id=T12070095)[42](https://app.finbar.com/go?id=P76989544)

In its second-quarter 2026 reporting, the company combined Imaging and AVS into a new reportable segment, Advanced Imaging Solutions (AIS), comprising Radiology, Specialized Ultrasound and Procedural Guidance; the company also said historical segment information was recast. [43](https://app.finbar.com/go?id=P144155523) Accordingly, the percentages above describe the 2025 segment structure, not the revised 2026 structure.
[31](https://app.finbar.com/go?id=T12070095)[32](https://app.finbar.com/go?id=P19851741)[33](https://app.finbar.com/go?id=P53323836)[6](https://app.finbar.com/go?id=P20467286)[7](https://app.finbar.com/go?id=P85204909)[8](https://app.finbar.com/go?id=P6558573)[9](https://app.finbar.com/go?id=P38308709)[10](https://app.finbar.com/go?id=P78624346)[13](https://app.finbar.com/go?id=P91589918)[14](https://app.finbar.com/go?id=P29609717)[15](https://app.finbar.com/go?id=P99511486)[34](https://app.finbar.com/go?id=P53536457)[35](https://app.finbar.com/go?id=P94434843)[36](https://app.finbar.com/go?id=P95678361)[16](https://app.finbar.com/go?id=P53106049)[17](https://app.finbar.com/go?id=P81258573)[37](https://app.finbar.com/go?id=P61448767)[18](https://app.finbar.com/go?id=P121080232)[38](https://app.finbar.com/go?id=P67720151)[39](https://app.finbar.com/go?id=P16267018)[40](https://app.finbar.com/go?id=P9360703)[19](https://app.finbar.com/go?id=P37389307)[41](https://app.finbar.com/go?id=P116356463)[20](https://app.finbar.com/go?id=P28638867)[21](https://app.finbar.com/go?id=P22466455)[42](https://app.finbar.com/go?id=P76989544)[43](https://app.finbar.com/go?id=P144155523)[31](https://app.finbar.com/go?id=T12070095)[31](https://app.finbar.com/go?id=T12070095)[31](https://app.finbar.com/go?id=T12070095)[31](https://app.finbar.com/go?id=T12070095)

## Company history

GE HealthCare’s history grew out of General Electric’s medical-technology work. GE’s corporate roots date to 1892; in 1896, Elihu Thomson built X-ray equipment and demonstrated stereoscopic images, and in 1913 William Coolidge developed the hot-cathode, high-vacuum X-ray tube. Later imaging milestones included GE’s 7800 CT system in 1978 and its 1.5T MRI scanner in 1983. [44](https://www.ge.com/history-ge-healthcare) [45](https://signapulse.gehealthcare.com/autumn-2024/signa-mr-see-the-future-change-the-outcome)

GE expanded its ultrasound business through the acquisitions of Diasonics Vingmed in 1998 and Kretztechnik in 2001. Its 2004 acquisition of Amersham brought diagnostic-imaging agents and life-sciences businesses into GE Medical Systems under the GE Healthcare name. After GE announced plans to separate its healthcare business in 2021, GE HealthCare became an independent public company on January 3, 2023, when GE distributed approximately 80.1% of its shares to GE stockholders; its shares began trading on Nasdaq as GEHC. [46](https://www.gehealthcare.com/en-us/about/newsroom/press-releases/ge-healthcare-completes-acquisition-of-bk-medical) [47](https://www.ge.com/news/press-releases/ge-acquires-amersham-95-billion-800p-share-offer-all-stock-transaction) [48](https://www.ge.com/news/press-releases/ge-completes-acquisition-amersham-transactionwill-shape-new-age-patient-care) [49](https://www.ge.com/news/press-releases/ge-plans-to-form-three-public-companies-focused-on-growth-sectors-of-aviation) [50](https://app.finbar.com/go?id=P19099841)
[50](https://app.finbar.com/go?id=P19099841)[44](https://www.ge.com/history-ge-healthcare)[45](https://signapulse.gehealthcare.com/autumn-2024/signa-mr-see-the-future-change-the-outcome)[46](https://www.gehealthcare.com/en-us/about/newsroom/press-releases/ge-healthcare-completes-acquisition-of-bk-medical)[47](https://www.ge.com/news/press-releases/ge-acquires-amersham-95-billion-800p-share-offer-all-stock-transaction)[48](https://www.ge.com/news/press-releases/ge-completes-acquisition-amersham-transactionwill-shape-new-age-patient-care)[49](https://www.ge.com/news/press-releases/ge-plans-to-form-three-public-companies-focused-on-growth-sectors-of-aviation)

## Sources

1. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P22478598)
2. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P102185265)
3. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P79435366)
4. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P25583711)
5. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=T7780819)
6. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P20467286)
7. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P85204909)
8. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P6558573)
9. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P38308709)
10. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P78624346)
11. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P61384239)
12. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P113702022)
13. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P91589918)
14. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P29609717)
15. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P99511486)
16. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P53106049)
17. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P81258573)
18. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P121080232)
19. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P37389307)
20. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P28638867)
21. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P22466455)
22. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P58194947)
23. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P46885042)
24. [GE HealthCare Technologies Inc. — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=T16498076)
25. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=T2474700)
26. [GE HealthCare Technologies Inc. — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=T16498074)
27. [careers.gehealthcare.com](https://careers.gehealthcare.com/global/en/about-gehc)
28. [careers.gehealthcare.com](https://careers.gehealthcare.com/global/en/locations)
29. [www.gehealthcare.com](https://www.gehealthcare.com/en/about/ge-healthcare-offices)
30. [investor.gehealthcare.com](https://investor.gehealthcare.com/news-releases/news-release-details/ge-healthcare-invests-138-million-cork-ireland-manufacturing)
31. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=T12070095)
32. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P19851741)
33. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P53323836)
34. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P53536457)
35. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P94434843)
36. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P95678361)
37. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P61448767)
38. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P67720151)
39. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P16267018)
40. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P9360703)
41. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P116356463)
42. [GE HealthCare Technologies Inc. — Full financial report (2025 Y)](https://app.finbar.com/go?id=P76989544)
43. [GE HealthCare Technologies Inc. — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P144155523)
44. [www.ge.com](https://www.ge.com/history-ge-healthcare)
45. [signapulse.gehealthcare.com](https://signapulse.gehealthcare.com/autumn-2024/signa-mr-see-the-future-change-the-outcome)
46. [www.gehealthcare.com](https://www.gehealthcare.com/en-us/about/newsroom/press-releases/ge-healthcare-completes-acquisition-of-bk-medical)
47. [www.ge.com](https://www.ge.com/news/press-releases/ge-acquires-amersham-95-billion-800p-share-offer-all-stock-transaction)
48. [www.ge.com](https://www.ge.com/news/press-releases/ge-completes-acquisition-amersham-transactionwill-shape-new-age-patient-care)
49. [www.ge.com](https://www.ge.com/news/press-releases/ge-plans-to-form-three-public-companies-focused-on-growth-sectors-of-aviation)
50. [GE HealthCare Technologies Inc. — Full financial report (2022 Y)](https://app.finbar.com/go?id=P19099841)

AI-generated summary; may contain errors. Not investment advice. Sign up to Finbar to view original document sources and access worldwide fundamental financial data and intelligence.